Regulatory Affairs and Pharmacovigilance in Belarus: A Practical Guide for Pharma Companies
Introduction Belarus is an important pharmaceutical market within the Eurasian Economic Union (EAEU). Companies seeking to register, manufacture or distribute medicinal products in the country must navigate national legislation alongside the EAEU’s harmonised regulatory framework. The Ministry of Health of the Republic of Belarus oversees national medicines policy, while the Center for Expertise and Testing in Health Care plays an important role in the expert assessment of medicinal products. EAEU requirements also influence registration dossiers, good manufacturing practice (GMP) and pharmacovigilance. For pharmaceutical companies, understanding how these systems interact is essential. A well-planned regulatory approach can support efficient submissions, reliable safety monitoring and consistent product quality throughout the lifecycle. 1. Understanding Belarus’s Pharmaceutical Regulatory Framework Belarus regulates medicinal products through national legislation, including the Law on...